Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients

Aliment Pharmacol Ther. 2019 Oct;50(7):837-838. doi: 10.1111/apt.15467.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Diabetes Mellitus*
  • Humans
  • Hypoglycemic Agents
  • Liver Cirrhosis
  • Liver Neoplasms*
  • Metformin*

Substances

  • Hypoglycemic Agents
  • Metformin